jorveza
dr. falk pharma gmbh - budesonide - malattie esofagee - antidiarrheals, intestinali antiinfiammatori / antinfettivo agenti - jorveza è indicato per il trattamento della esofagite eosinofila (eoe) negli adulti (di età superiore a 18 anni).
gibiter
menarini international operations luxembourg s.a. - formoterolo e budesonide - formoterolo e budesonide
trixeo aerosphere
astrazeneca ab - formoterol fumarate dihydrate, glycopyrronium bromide, budesonide - malattia polmonare, ostruttiva cronica - farmaci per le malattie respiratorie ostruttive, - trixeo aerosphere is indicated as a maintenance treatment in adult patients with moderate to severe chronic obstructive pulmonary disease (copd) who are not adequately treated by a combination of an inhaled corticosteroid and a long acting beta2 agonist or combination of a long-acting beta2 agonist and a long acting muscarinic antagonist.
assieme mite
simesa s.p.a. - formoterolo e budesonide - formoterolo e budesonide
fobuler
orion corporation - formoterolo e budesonide - formoterolo e budesonide
symbicortmite
astrazeneca s.p.a. - formoterolo e budesonide - formoterolo e budesonide
budineb
i.b.n. savio s.r.l - budesonide - budesonide
budiair
chiesi farmaceutici s.p.a. - budesonide - budesonide
deso
master pharma s.r.l. - budesonide - budesonide
intesticort
dr. falk pharma gmbh - budesonide - budesonide